Alexion

Sunday 24 September 10.15-11.00 hrs. - Crystal Hall:

  • Key Advances in PNH (paroxysmal nocturnal hemoglobinuria) testing

Speakers:

  • Mrs Andrea Illingworth (Dahl Chase diagnostics services, Bangor, US
  • Dr Rob Sutherland  (University Health Network, Toronto, Canada)

Objective:

  • To educate cytometrists on the diagnostic of PNH and clinical indications that warrant testing
  • To discuss latest advances related to diagnosis of PNH by flow cytometry, including  existing guidelines for diagnosis and monitoring of PNH by flow cytometry

Programme:

10.15-10.20   Welcome & Introduction - D. Sutherland
10.20-10.35   Clinical indications warranting testing for PNH, Reagents and Instrument optimization - D. Sutherland
10.35-10.50   PNH diagnosis, assay validation, data interpretation and reporting - A. Illingworth
10.50-11.00   Q&A

 
Beckman Coulter 

Sunday 24 September 18.00 hrs. - Exhibition Hall stand PR1:

  • Booth reception and lecture
    Leo Koenderman:
    Applications in the AQUIOS Designer Software on AQUIOS allow 24/7 immune monitoring in trauma patients

Monday 25 September 12.30-13.15 hrs. - Crystal Hall: 

  • ESCCA Scientific Industrial Partner Presentation 
    Katherina Psarra and Michael Kapinsky: 
    ClearLLab LS: A new CE-IVD orientation tube to guide you through diagnosis of hematolymphoid malignancies

Monday 25 & Tuesday 26 September - V.I.P. Lounge: 

  • Meet the Expert Sessions
    For an overview of the time slots and to reserve your slot, please click the link mentioned in the activities programme

 

Sysmex Europe GmbH

Tuesday 26 September 10.15-11.00 hrs. - Crystal Hall:

  • ESCCA Scientific Industrial Partner Presentation

A new enumeration method for hematopoietic stem cell collection management
Harriet Klinkspoor

Speakers details: Dr. Harriet Klinkspoor is a clinical chemist, specialized in haematology. She works in the Academic Medical Center in Amsterdam, The Netherlands, where she is the Head of the Laboratory for Specialized Haematology.

CD34 flow cytometry is the gold standard for stem cell enumeration in peripheral blood at the mobilization stage and in the final apheresis product. The new stem cell mode of the Sysmex XN Series analyzer enumerates an immature cell population in the WPC channel, based on the cell size, internal cellular complexity and fluorescence intensity. In a multicenter study we analyzed 147 peripheral blood samples, 22 samples during collection of stem cells and 45 samples from the apheresis product of 18 healthy allogeneic donors and 84 autologous patients. Our study demonstrates that the XN stem cell enumeration method correlates well with viable CD34+ cells determined by flow cytometry during stem cell mobilization phase to determine apheresis start time, during apheresis for real-time monitoring and adjustment and for quality control of the final stem cell harvest. The XN stem cell enumeration method has a number of advantages compared to CD34 flow cytometry: it is fast, simple, reproducible and less expensive. CE marking for the European market has been obtained, making the stem cell count on the XN analyzer a reportable clinical parameter.

 

Corporate Lectures

Sunday 24 September 13.00-13.30 hrs. - Crystal Hall: 

  • Cytognos: Infinicyt 2.0 NGF (next generation flow) - download abstract
    Mariona Ramos, Biochemistry Phd. Cytognos Product Specialist